Current Therapeutic Options for Controlled Ovarian Stimulation in Assisted Reproductive Technology
| Autor: | Annalisa Racca, Ana Raquel Neves, Panagiotis Drakopoulos, Nikolaos P. Polyzos |
|---|---|
| Přispěvatelé: | Faculty of Medicine and Pharmacy, Centre for Reproductive Medicine - Gynaecology, Surgical clinical sciences |
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Process management
Reproductive Techniques Assisted Emerging technologies LIVE BIRTH-RATES medicine.medical_treatment Pharmacology toxicology surgery 03 medical and health sciences HUMAN CHORIONIC-GONADOTROPIN 0302 clinical medicine medicine Humans Pharmacology (medical) FERTILIZATION/INTRACYTOPLASMIC SPERM INJECTION GNRH ANTAGONIST PROTOCOL HIGHLY PURIFIED HMG FINAL OOCYTE MATURATION LUTEAL-PHASE SUPPORT In vitro fertilisation Assisted reproductive technology business.industry ORAL-CONTRACEPTIVE PILL Research findings Clinical Practice 030220 oncology & carcinogenesis ovulation Female ovulation induction HORMONE ANTAGONIST IN-VITRO FERTILIZATION business 030217 neurology & neurosurgery reproductive medicine |
| Zdroj: | Racca, A, Drakopoulos, P, Neves, A R & Polyzos, N P 2020, ' Current Therapeutic Options for Controlled Ovarian Stimulation in Assisted Reproductive Technology ', Drugs, vol. 80, no. 10, pp. 973-994 . https://doi.org/10.1007/s40265-020-01324-w |
| DOI: | 10.1007/s40265-020-01324-w |
| Popis: | Assisted reproduction technologies have substantially advanced since the birth of the first in vitro fertilization baby, and innovations within in vitro fertilization laboratories have been of paramount importance for the overall assisted reproduction technology success rates. However, one of the milestones in the history of in vitro fertilization is irrefutably the introduction of conventional ovarian stimulation. The objective of the present review is to provide an update on conventional ovarian stimulation, by giving an overview of treatment milestones, together with the latest innovations currently being investigated. The realization of an assisted reproduction technology treatment depends on many steps that can be medically manipulated and must be harmoniously combined, starting from the follicular phase and ending with luteal phase support. New technologies in the pharmaceutical sector are fundamental to optimize efficiency and tailor treatment approaches to individual needs. The present review aims to offer physicians a useful summary of the more recent publications and to facilitate the translation of research findings into daily clinical practice. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|